Novabiotics - a leading clinical-stage biotechnology company
Novabiotics about us Novabiotics clinical studies Novabiotics pipeline Novabiotics our news Novabiotics contact
Date posted: 23 April 2024

Three Posters on New Lynovex Preclinical and Clinical Data to be presented at NACFC, 31st October to 2nd November 2019, Nashville Tennessee.

Dr Douglas Fraser-Pitt will present three posters on Thursday 31st October 2019 at https://www.nacfconference.org…

11:15 a.m. – 1:45 p.m. in the Exhibit Hall.

Poster number 499

‘CYSTEAMINE INHIBITS MULTIPLE VIRULENCE TRAITS OF CF-ASSOCIATED PATHOGENS’

Poster number 492

‘THE EFFECT OF CYSTEAMINE FORMULATED FOR DRY POWDER INHALATION (DPI) ON CYSTIC FIBROSIS SPUTUM RHEOLOGY’

Poster number 494

‘CYSTEAMINE DISRUPTS KEY ASPECTS OF METABOLISM IN P. AERUGINOSA’